Moreover, SLC3A2 and SLC7A5 expression is high in plasma cells and dependent on the transcription factor PRDM148, a master regulator of plasma cell differentiation49 and an essential MM gene (Fig. 1b). The gene discussed is SLC7A5; the disease is Miyoshi myopathy.